Assessment of Liver Stiffness in Pediatric Fontan Patients Using Transient Elastography

Becky Chen1, Richard A Schreiber1, Derek G Human2

  • 1Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada; Division of Gastroenterology, Hepatology and Nutrition, British Columbia Children's Hospital, Vancouver, BC, Canada.

Insights

Pediatric Fontan patients show significantly higher liver stiffness, indicating potential fibrosis. Transient elastography (TE) is a feasible, noninvasive tool for monitoring liver health in these children.

Area of Science:

  • Pediatric Cardiology
  • Hepatology
  • Noninvasive Diagnostics

Background:

  • Hepatic fibrosis is a known complication post-Fontan surgery, increasing cirrhosis risk.
  • Transient elastography (TE) offers a rapid, noninvasive method for assessing liver stiffness and fibrosis.
  • Monitoring liver health is crucial for long-term outcomes in Fontan patients.

Purpose of the Study:

  • To compare liver stiffness in pediatric Fontan patients versus age- and sex-matched controls.
  • To evaluate liver biochemistries in the same cohorts.
  • To determine patient acceptance and feasibility of TE in this population.

Main Methods:

  • Twenty-two pediatric Fontan patients were recruited from British Columbia Children's Hospital.
  • Demographic, cardiac data, and transient elastography (TE) measurements were collected.
  • TE values were compared to age- and sex-matched healthy controls.

Main Results:

  • Fontan patients exhibited significantly higher liver stiffness (median 18.6 kPa) compared to controls (median 4.7 kPa) (p < 0.001).
  • No significant association was found between TE values and patient age, time since surgery, or Fontan circuit pressure.
  • Patients reported TE as nonpainful, convenient, and safe.

Conclusions:

  • Transient elastography is a feasible method for assessing liver stiffness in pediatric Fontan patients.
  • Pediatric Fontan survivors demonstrate markedly elevated liver stiffness.
  • TE holds significant potential for routine liver care follow-up in this high-risk group.